Provided by Tiger Trade Technology Pte. Ltd.

Adaptive Biotechnologies Corp

25.66
-0.3300-1.27%
Volume:353.91K
Turnover:9.02M
Market Cap:4.10B
PE:-62.39
High:25.90
Open:25.63
Low:25.10
Close:25.99
52wk High:26.16
52wk Low:12.00
Shares:159.76M
Float Shares:125.00M
Volume Ratio:0.58
T/O Rate:0.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4113
EPS(LYR):-0.3922
ROE:-38.76%
ROA:-4.12%
PB:28.68
PE(LYR):-65.43

Loading ...

Adaptive Biotechnologies Director Peter M. Neupert Disposes of 124,690 Common Shares for $3.14 Million

Reuters
·
Aug 20

Adaptive Biotechnologies (ADPT) Stock Looks Fair On Cash Flow Yet Rich On Sales

Simply Wall St.
·
Aug 13

Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky Sells 3,000 Shares for $75,000

Reuters
·
Aug 13

Adaptive Biotechnologies is Maintained at Overweight by Piper Sandler

Dow Jones
·
Aug 04

U.S. Research Roundup-Cloudflare, Replimune, Walmart

Reuters
·
Aug 04

Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky Disposes of 1,299 Common Shares for $31,176

Reuters
·
Aug 04

Veracyte Q2 Revenue Rises on Decipher and Afirma Test Sales

Reuters
·
Jul 31

Fulgent Genetics Q2 Revenue Rises 20% Sequentially, Sees Billing System Transition Delay

Reuters
·
Jul 31

CareDx Q2 Revenue Beats Estimates; Outlook Lifted

Reuters
·
Jul 31

Adaptive Biotechnologies is Maintained at Buy by Guggenheim

Dow Jones
·
Jul 30

Adaptive Biotechnologies price target raised to $25 from $24 at BTIG

TIPRANKS
·
Jul 30

Adaptive Biotechnologies Corp : Morgan Stanley Raises Target Price to $22 from $20

THOMSON REUTERS
·
Jul 30

U.S. Research ROUNDUP-Equinix, Meta, S&P Global

Reuters
·
Jul 30

Adaptive Biotechnologies Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 30

Adaptive Biotechnologies Q2 Net Loss Widens to $39.9 Million; Revenue Rises 22% to $71.6 Million

Reuters
·
Jul 30

Adaptive Biotechnologies Shares Drop 6.9% in Extended Trading After Posting Quarterly Results

THOMSON REUTERS
·
Jul 30

Adaptive Biotechnologies Q2 EPS $(0.25) Misses $(0.14) Estimate, Sales $71.553M Beat $65.886M Estimate

Benzinga Earnings
·
Jul 30

Adaptive Biotechnologies Q2 EPS USD -0.25

Reuters
·
Jul 30

Adaptive Biotechnologies Expects Fy2026 Mrd Revenue $268 Mln-$278 Mln

THOMSON REUTERS
·
Jul 30

Adaptive Biotechnologies Q2 Adjusted Ebitda USD -700 Thousand

THOMSON REUTERS
·
Jul 30